Brief: Cumberland Pharmaceuticals Announces FDA Orphan Drug Grant Award For New Phase II Clinical Program
24/09/2019 18:07
Sept 24 (Reuters) - Cumberland Pharmaceuticals Inc CPIX.O :
* CUMBERLAND PHARMACEUTICALS ANNOUNCES FDA ORPHAN DRUG GRANT
AWARD
FOR NEW PHASE II CLINICAL PROGRAM
* CUMBERLAND PHARMACEUTICALS INC - HAS BEEN AWARDED JUST
OVER $1
MILLION IN FUNDING FROM FDA THROUGH THEIR ORPHAN DRUG GRANT
PROGRAM
Source text for Eikon: urn:newsml:reuters.com:*:nPn68g4bNa
Further company coverage: CPIX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cumberland Pharmaceuticals
See all newsBrief: Cumberland Pharmaceuticals Announces Assist-Ssc Trial Top-Line Results
Cumberland Pharmaceuticals Q2 loss widens after Apotex transaction
Brief: Cumberland Pharmaceuticals Announces Special Dividend Of $1.50 Per Share
Cumberland Pharmaceuticals Q1 revenue up 5%; to sell FDA‑approved brands to Apotex for $100 mln
NASDAQ RESUMED AT 09:38 AM